BPG is committed to discovery and dissemination of knowledge
            
            
                
                
                    
    Articles Published Processes
    
        12/27/2021 5:24:00 AM | Browse: 383 | Download: 1304
    
    
        
        
    
        | 
                
                    |  | Received |  | 2021-01-04 19:10 | 
    
        | 
                
                    |  | Peer-Review Started |  | 2021-01-04 19:10 | 
    
        | 
                
                    |  | To Make the First Decision |  |  | 
    
        | 
                
                    |  | Return for Revision |  | 2021-07-08 07:00 | 
    
        | 
                
                    |  | Revised |  | 2021-07-22 09:36 | 
    
        | 
                
                    |  | Second Decision |  | 2021-11-22 03:35 | 
    
        | 
                
                    |  | Accepted by Journal Editor-in-Chief |  |  | 
    
        | 
                
                    |  | Accepted by Executive Editor-in-Chief |  | 2021-11-25 02:29 | 
    
        | 
                
                    |  | Articles in Press |  | 2021-11-25 02:29 | 
    
        | 
                
                    |  | Publication Fee Transferred |  |  | 
    
        | 
                
                    |  | Edit the Manuscript by Language Editor |  |  | 
    
        | 
                
                    |  | Typeset the Manuscript |  | 2021-12-21 04:09 | 
            
                | 
                        
                            |  | Publish the Manuscript Online |  | 2021-12-27 05:24 | 
        
        
            
                | ISSN | 1948-5182 (online) | 
            
                | Open Access | This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ | 
            
                | Copyright | © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. | 
                    
                        | Article Reprints | For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247 | 
            
            
                | Permissions | For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207 | 
            
            
                | Publisher | Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | 
            
                | Website | http://www.wjgnet.com | 
        
    
        | Category | Medicine, General & Internal | 
    
        | Manuscript Type | Case Control Study | 
    
        | Article Title | Leukocyte cell-derived chemotaxin-2 and fibroblast growth factor 21 in alcohol-induced liver cirrhosis | 
    
        | Manuscript Source | Unsolicited Manuscript | 
    
        | All Author List | Jarosław Jerzy Sak, Andrzej Prystupa, Paweł Kiciński, Dorota Luchowska-Kocot, Ewa Kurys-Denis and Hanna Bis-Wencel | 
            
                | ORCID |  | 
    
        | Funding Agency and Grant Number | 
                        
                            
                                | Funding Agency | Grant Number |  
                                        | Grant from the Medical University of Lublin | DS 507/2013–2015 |  | 
    
        | Corresponding Author | Jarosław Jerzy Sak, MD, PhD, Academic Research, Additional Professor, Director, Director, Chair and Department of Humanities and Social Medicine, Medical University of Lublin, ul. Chodźki 7 (Collegium Academicum), Lublin 20-093, Poland. jaroslaw.sak@umlub.pl | 
    
        | Key Words | Leukocyte cell-derived chemotaxin-2; Fibroblast growth factor 21; Fibroblast growth factor 1; Alcoholic liver cirrhosis; Pugh-Child score | 
    
        | Core Tip | Leukocyte cell-derived chemotaxin-2 (LECT2) was first described in 1996 as a novel chemotactic factor for neutrophils. It has been widely studied to determine its usefulness for monitoring the course of non-alcoholic fatty liver disease but not for alcoholic liver cirrhosis (ALC). We suggest that LECT2 may be used for the non-invasive diagnosis of ALC. | 
            
                | Publish Date | 2021-12-27 05:24 | 
    
        | Citation | Sak JJ, Prystupa A, Kiciński P, Luchowska-Kocot D, Kurys-Denis E, Bis-Wencel H. Leukocyte cell-derived chemotaxin-2 and fibroblast growth factor 21 in alcohol-induced liver cirrhosis. World J Hepatol 2021; 13(12): 2071-2080 | 
            
                | URL | https://www.wjgnet.com/1948-5182/full/v13/i12/2071.htm | 
            
                | DOI | https://dx.doi.org/10.4254/wjh.v13.i12.2071 | 
    
    
        
                
        
     
 
                 
             
         
        
    
        
        
            © 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
            California Corporate Number: 3537345